ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1352
0.71%
Brent Oil
85.93
-1.55%
Bitcoin
60,080.58
-5.88%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Castle Biosciences Inc (CSTL)

  7. Castle Biosciences Inc (CSTL) Noticias

CSTL Castle Biosciences Inc

21.09
-0.44 (-2.04%)
Fuera de horario
Última actualización: 15:01:15
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Castle Biosciences Inc CSTL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.44 -2.04% 21.09 15:01:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
21.23 20.81 21.43 21.09 21.53
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:30BWCastle Biosciences Kicks off Skin Cancer Awareness Month..
11/4/202406:00BWCastle Biosciences to Release First Quarter 2024 Financial..
10/4/202416:00BWCastle Biosciences Celebrates Esophageal Cancer Awareness..
10/4/202406:00BWCastle Biosciences’ Chief Financial Officer Frank Stokes..
04/4/202415:30BWPresentations at EADO Highlight Potential Impact of Castle..
02/4/202406:00BWCastle Biosciences to Present at the 23rd Annual Needham..
27/3/202416:00BWCastle Biosciences Announces Updates to its Board of..
25/3/202406:00BWCastle Biosciences Earns a Top Workplaces USA Award for the..
22/3/202415:30BWLong-term Outcomes Data Shared at SSO 2024 Show That..
19/3/202406:00BWLeading Squamous Cell Carcinoma Practitioners Publish..
15/3/202415:30BWNew Study Shows that the Drug-Drug Interactions and..
12/3/202406:00BWCastle Biosciences to Present at the KeyBanc Capital Markets..
08/3/202415:30BWCastle Biosciences to Present New Data Highlighting the..
07/3/202406:00BWIn Novel Cohort, New Data Confirms DecisionDx®-SCC Provides..
06/3/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202415:05BWCastle Biosciences Reports Fourth Quarter and Full-Year 2023..
26/2/202406:00BWStudy Finds DecisionDx®-Melanoma Significantly Improves the..
07/2/202406:00BWCastle Biosciences to Release Fourth Quarter and Full-Year..
18/1/202406:00BWNew Study Highlights Significant Potential Medicare Savings..
14/1/202403:30BWCastle Biosciences Presents Data Supporting the Utility of..
09/1/202406:00BWCastle Biosciences’ Chief Operating Officer Kristen..
08/1/202406:04EDGAR2Form 8-K - Current report
07/1/202419:00BWCastle Biosciences Announces Preliminary Fourth Quarter and..
04/1/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:00BWCastle Biosciences Reports Inducement Grants Under Nasdaq..
12/12/202318:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/12/202306:00BWStudy Finds Nurse Practitioners and Physician Assistants..
14/11/202306:00BWCastle Biosciences Announces Multiple Data Presentations at..
13/11/202306:00BWCastle Biosciences Ranked Among the Top Workplaces in..
09/11/202316:25EDGAR2Form 8-K - Current report
08/11/202315:30BWReal-World Evidence Confirms IDgenetix®-Guided Medication..
08/11/202312:00BWCastle Biosciences to Present at Upcoming Investor..
03/11/202306:00BWCastle Announces Early Exploratory Study Data for Potential..
02/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:06BWEarly Discovery Data Shows Ability of Castle Biosciences’..
02/11/202315:05BWCastle Biosciences Reports Third Quarter 2023 Results
24/10/202306:00BWCastle Biosciences to Present New Data on its TissueCypher®..
19/10/202306:00BWCastle Biosciences to Release Third Quarter 2023 Financial..
18/10/202315:30BWNew Data Highlights Clinical Utility and Performance of..
05/10/202306:00BWDecisionDx®-Melanoma Outperforms Memorial Sloan Kettering..
03/10/202306:00BWCastle Biosciences Presents New Data at ASTRO 2023..
02/10/202306:00BWCastle Biosciences Shares New Data Demonstrating Ability of..
25/9/202306:00BWCastle Biosciences, Leading Skin Cancer Expert, Darrell..

Su Consulta Reciente

NASDAQ
CSTL
Castle Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados